Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate

Spine

Volumn 27, Issue 4, 2002, Pages 353-360

  Suh, Dan Y ^a   Boden, Scott D ^a,b   Louis Ugbo, John ^a   Mayr, Matthew ^a   Murakami, Hideki ^a   Kim, Hak Sun ^a   Minamide, Akihito ^a   Hutton, William C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Bone graft substitute; Ceramic; Compression resistant matrices; Hydroxyapatite; Nonhuman primate; Rabbit; Recombinant human bone morphogenetic protein 2; Spinal fusion; Tricalcium phosphate

Indexed keywords

CALCIUM PHOSPHATE; COLLAGEN TYPE 1; HYDROXYAPATITE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL EXPERIMENT; ARTHRODESIS; ARTICLE; AUTOGRAFT; BIOMECHANICS; BONE GRAFT; CERAMIC PROSTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; HISTOLOGY; NONHUMAN; PALPATION; PRIMATE; PRIORITY JOURNAL; RABBIT; RHESUS MONKEY; SPINE FUSION; SPINE RADIOGRAPHY; TENSILE STRENGTH; VERTEBRA;

ANIMALS; BIOMECHANICS; BONE MORPHOGENETIC PROTEINS; CALCIUM PHOSPHATES; CERAMICS; COLLAGEN TYPE I; COMPRESSIVE STRENGTH; DRUG ADMINISTRATION ROUTES; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; DURAPATITE; HUMANS; IMPLANTS, EXPERIMENTAL; LUMBAR VERTEBRAE; LUMBOSACRAL REGION; MACACA MULATTA; MODELS, ANIMAL; OSTEOGENESIS; RABBITS; RECOMBINANT PROTEINS; SPINAL FUSION; SURGICAL SPONGES; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 0037082557     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-200202150-00006     Document Type: Article

References (16)

1. Posterolateral lumbar intertransverse process spine arthrodesis with rhBMP-2/hydroxyapatite-tricalcium phosphate (HA-TCP) following laminectomy in the non-human primate
2. 1995 Volvo Award in Basic Sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species
3. An experimental lumbar intertransverse process spinal fusion model: Radiographic, histologic, and biomechanical healing characteristics
4. In vivo evaluation of a resorbable osteoinductive composite as a graft substitute for lumbar spinal fusion
5. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report
6. Lumbar spinal fusion using recombinant human bone morphogenetic protein-2 (rhBMP-2): A randomized, blinded and controlled study
7. Hydroxyapatite ceramic as a bone substitute
8. Tri-calcium phosphate ceramics and allografts as bone substitutes for spinal fusion in idiopathic scoliosis: Comparative clinical results at four years
9. Posterolateral intertransverse process spinal fusion arthrodesis with rhBMP-2 in a non-human primate: Important lessons learned regarding dose, carrier, and safety
10. Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model
11. Carriers for bone morphogenetic protein for posterolateral spinal fusion
12. Macroporous calcium phosphate ceramic performance in human spine fusion
13. Effective doses of recombinant bone morphogenetic protein-2 in experimental spinal fusion
14. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model
15. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 (rhBMP-2)
16. Anterior lumbar interbody fusion: Surgical technique